AMRN - Amarin Corporation plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

2.79

-0.03 (-1.06%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	2.82
Open	2.82
Bid	0.00 x 0
Ask	0.00 x 0
Day's Range	2.76 - 2.86
52 Week Range	2.76 - 4.60
Volume	3,825,787
Avg. Volume	2,177,300

Market Cap	819.099M
Beta	1.12
PE Ratio (TTM)	N/A
EPS (TTM)	-0.25
Earnings Date	May 3, 2017 - May 8, 2017
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	7.60

Trade prices are not sourced from all markets

All

News

Press Releases

Zacks19 hours ago
Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
GlobeNewswire2 days ago
Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer
BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
GlobeNewswire12 days ago
New Research: Key Drivers of Growth for Amarin, Korea Electric Power, Star Bulk Carriers, 1-800 FLOWERS.COM, Clementia Pharmaceuticals, and Bank of Nova Scotia — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, April 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
GlobeNewswire12 days ago
Amarin Sponsors Three Scientific Presentations Scheduled for National Lipid Association Scientific Sessions
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Zacks13 days ago
Moving Average Crossover Alert: Amarin (AMRN)
Amarin Corporation plc (AMRN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
GlobeNewswire13 days ago
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin-Treated Patients with Reduced Kidney Function and Persistent High Triglycerides
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
ACCESSWIRE19 days ago
Wired News – Amarin’s REDUCE-IT Study Reached 100% Mark for Estimated Onset of Targeted Primary MACE
Stock Monitor: Pernix Therapeutics Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 6, 2018 / Active-Investors.com has just released a free research report on Amarin Corp. PLC (NASDAQ: ...
Motley Fool20 days ago
Boom-or-Bust News Is On Tap Soon for Amarin
Amarin has needle-moving news that's fast-approaching.
GlobeNewswire21 days ago
Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives
BEDMINSTER, N.J. and DUBLIN, Ireland, April 04, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
GlobeNewswire21 days ago
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events
BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Zacks23 days ago
Implied Volatility Surging for Amarin (AMRN) Stock Options
Surging implied volatility makes Amarin (AMRN) stock lucrative to the option traders.
Investopedia23 days ago
7 Stocks for the Biotech Takeover Wave
Biotech M&A activity took a bit of a breather in 2017, but expect a new wave of deals in 2018.
Thomson Reuters StreetEvents25 days ago
Edited Transcript of AMRN earnings conference call or presentation 27-Feb-18 12:30pm GMT
Q4 2017 Amarin Corporation PLC Earnings Call
GlobeNewswire27 days ago
Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings
BEDMINSTER, N.J. and DUBLIN, Ireland, March 29, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
GlobeNewswire27 days ago
Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference
BEDMINSTER, N.J. and DUBLIN, Ireland, March 28, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
GlobeNewswire28 days ago
Amarin Commemorates National Triglycerides Day on March 28
BEDMINSTER, N.J. and DUBLIN, Ireland, March 27, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
GlobeNewswirelast month
Amarin Announces First Middle East Approval for Vascepa®
BEDMINSTER, N.J. and DUBLIN, Ireland, March 21, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
Motley Foollast month
3 Stocks That Could Put Alibaba's Returns to Shame
Alibaba may make the headlines, but here are three other stocks that are equally strong investment opportunities.
GlobeNewswirelast month
New Research Coverage Highlights Amarin, Corbus Pharmaceuticals, Green Brick Partners, Immutep, Texas Capital Bancshares, and G1 THERAPEUTICS — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, March 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
GlobeNewswirelast month
Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs
BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
GlobeNewswirelast month
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipids and Inflammatory Markers in Patients With Persistent High Triglycerides and Elevated High-Sensitivity C-Reactive Protein (hsCRP)
BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
CNBC2 months ago
Cramer's lightning round: I screwed up on Apache and won't stop you from selling
Jim Cramer zooms through his take on callers' favorite stocks, including a mea culpa on one oil play.
GlobeNewswire2 months ago
Amarin Announces Closing of Underwriter’s Purchase of Additional Shares
BEDMINSTER, N.J., and DUBLIN, Ireland, March 05, 2018-- Amarin Corporation plc today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares, ...
Zacks2 months ago
Implied Volatility Surging for Amarin (AMRN) Stock Options
Surging implied volatility makes Amarin (AMRN) Stock lucrative to the option traders.
CNBC Videos2 months ago
Cramer's lightning round: I screwed up on Apache and won'...
Jim Cramer zooms through his take on callers' favorite stocks, including a mea culpa on one oil play.